FMC/$FMC

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About FMC

FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.

Ticker

$FMC
Sector

Primary listing

NYSE

Employees

5,700

FMC Metrics

BasicAdvanced
$4.7B
46.89
$0.80
0.76
$2.32
6.22%

What the Analysts think about FMC

Analyst ratings (Buy, Hold, Sell) for FMC stock.

Bulls say / Bears say

FMC’s strategic partnership with Corteva Agriscience broadens distribution of its high-margin fluindapyr fungicide across roughly 95 million acres of U.S. corn and 80 million acres of soybean markets, accelerating adoption of this novel resistance-management solution (PRNewswire)
The company’s growth portfolio rose by high-single digits in Q2 2025, driven by strong commercial uptake of new active ingredients such as fluindapyr and Isoflex, demonstrating effective execution of its R&D pipeline (PRNewswire)
FMC’s Plant Health business grew 3% in Q2 2025, led by biologicals, underscoring successful diversification into higher-growth, sustainable crop solutions (PRNewswire)
In Q1 2025, FMC’s revenue fell 14% year-over-year to $791 million, with organic sales down 10%, reflecting customer destocking and muted demand across key regions (PRNewswire)
In Q2 2025, FMC’s Asia sales declined 17% year-over-year (down 15% excluding currency impacts) due to lower pricing and ongoing channel destocking, highlighting persistent headwinds in a critical emerging market (PRNewswire)
Free cash flow in Q2 2025 was $40 million, down $241 million from Q2 2024, raising concerns about cash conversion amid higher working capital and inventory levels (PRNewswire)
Data summarised monthly by Lightyear AI. Last updated on 29 Aug 2025.

FMC Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

FMC Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $FMC

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Sept30
FMC
DividendEx-dividend
Oct16
FMC
DividendPayment
$0.58Per share
FAQs